Technical Analysis for BLUE - bluebird bio, Inc.

Grade Last Price % Change Price Change
D 1.28 -6.23% -0.09
BLUE closed down 6.23 percent on Thursday, March 28, 2024, on 75 percent of normal volume. It was able to find support at its 50 day moving average.
3 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Down

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
MACD Bearish Centerline Cross Bearish 0.00%
50 DMA Support Bullish 0.00%
Earnings Movers Other 0.00%
Crossed Above 50 DMA Bullish -6.23%
Expansion Pivot Buy Setup Bullish Swing Setup -6.23%
Earnings Movers Other -6.23%
Lower Bollinger Band Touch Weakness -6.23%
Fell Below 50 DMA Bearish 6.67%
Hammer Candlestick Bullish 6.67%

   Recent Intraday Alerts

Alert Time
Fell Below 50 DMA about 12 hours ago
50 DMA Support about 12 hours ago
Fell Below Lower Bollinger Band about 12 hours ago
Lower Bollinger Band Support about 12 hours ago
Down 5% about 14 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

bluebird bio, Inc. Description

bluebird bio, Inc., a clinical-stage biotechnology company, focuses on the development, manufacture, and marketing of therapies to treat various human diseases. Its product candidates include Lenti-D to treat patients with childhood cerebral adrenoleukodystrophy (ALD), a hereditary neurological disorder, as well as for the treatment of adult cerebral ALD; and CAR T cells products for treating oncology diseases. The company's product candidates also comprise LentiGlobin vector for the treatment of ß-thalassemia, a hereditary blood disorder; and sickle cell diseases. It has a strategic collaboration with Celgene Corporation to discover, develop, and commercialize disease-altering gene therapies in oncology. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was founded in 1992 and is headquartered in Cambridge, Massachusetts.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Rare Diseases Medical Genetics Dystrophy Human Diseases Summit Childhood Genetic Genealogy Sickle Cell Disease Thalassemia Iglo Oncology Diseases

Is BLUE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.53
52 Week Low 0.879
Average Volume 9,640,100
200-Day Moving Average 2.68
50-Day Moving Average 1.25
20-Day Moving Average 1.40
10-Day Moving Average 1.37
Average True Range 0.16
RSI (14) 46.24
ADX 21.25
+DI 24.89
-DI 20.66
Chandelier Exit (Long, 3 ATRs) 1.38
Chandelier Exit (Short, 3 ATRs) 1.56
Upper Bollinger Bands 1.56
Lower Bollinger Band 1.24
Percent B (%b) 0.12
BandWidth 23.10
MACD Line -0.01
MACD Signal Line 0.01
MACD Histogram -0.0193
Fundamentals Value
Market Cap 246.71 Million
Num Shares 193 Million
EPS -0.63
Price-to-Earnings (P/E) Ratio -2.03
Price-to-Sales 9.32
Price-to-Book 0.89
PEG Ratio 0.32
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.54
Resistance 3 (R3) 1.55 1.49 1.49
Resistance 2 (R2) 1.49 1.42 1.48 1.48
Resistance 1 (R1) 1.38 1.38 1.35 1.37 1.46
Pivot Point 1.32 1.32 1.30 1.31 1.32
Support 1 (S1) 1.21 1.25 1.18 1.20 1.10
Support 2 (S2) 1.15 1.21 1.14 1.08
Support 3 (S3) 1.04 1.15 1.07
Support 4 (S4) 1.03